A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 3.27 EUR 2.19% Market Closed
Market Cap: 248.3m EUR
Have any thoughts about
Atrys Health SA?
Write Note

Atrys Health SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atrys Health SA
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Atrys Health SA
MAD:ATRY
Cash & Cash Equivalents
€12.1m
CAGR 3-Years
-13%
CAGR 5-Years
56%
CAGR 10-Years
N/A
No Stocks Found

Atrys Health SA
Glance View

Market Cap
248.3m EUR
Industry
Health Care

Atrys Health SA is a biomedical company, which engages in the research and development of diagnostic services. The company is headquartered in Madrid, Madrid and currently employs 2,397 full-time employees. The company went IPO on 2016-07-22. The company operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. The company has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The firm has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

ATRY Intrinsic Value
5.33 EUR
Undervaluation 39%
Intrinsic Value
Price
A

See Also

What is Atrys Health SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
12.1m EUR

Based on the financial report for Jun 30, 2024, Atrys Health SA's Cash & Cash Equivalents amounts to 12.1m EUR.

What is Atrys Health SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
56%

Over the last year, the Cash & Cash Equivalents growth was -39%. The average annual Cash & Cash Equivalents growth rates for Atrys Health SA have been -13% over the past three years , 56% over the past five years .

Back to Top